C07D241/10 - CPC Classification Index

ClassID:

94533 ⎘

C07D241/10 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Sub-classes:

C07D241/12 » with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms 473
C07D241/14 » with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms 8

Recent Application in this class:

20250214946

2025-07-03

FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER INTERMEDIATE

20240336576

2024-10-10

FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER INTERMEDIATE

20220289687

2022-09-15

Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester

20220168284

2022-06-02

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

20210107880

2021-04-15

Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester

20200353441

2020-11-12

Highly stable [MaMbF6-n(O/H2O)n(Ligand)2(solvent)x]n metal organic frameworks

20200215039

2020-07-09

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

20200199082

2020-06-25

Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-N-protected amino ester

20200157063

2020-05-21

Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis

#10

20190282998

2019-09-19

Highly stable [MaMbF6-n(O/H2O)n(ligand)2(solvent)x]n metal organic frameworks

#11

20190091211

2019-03-28

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

#12

20180230107

2018-08-16

Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediate

#13

20180093250

2018-04-05

Highly stable [MaMbF6-n(O/H2O)n(ligand)2(solvent)x]n metal organic frameworks

#14

20170326149

2017-11-16

Hydroxyl purine compounds and applications thereof

#15

20170304279

2017-10-26

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

#16

20160137614

2016-05-19

Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino ester

#17

20150259301

2015-09-17

Formation of N-protected 3,6-bis-(4-aminobutyl) -2, 5-diketopiperazine through a cyclic α--protected active amino ester intermediate

#18

20140288304

2014-09-25

Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester

#19

20130252939

2013-09-26

Tri-cyclic pyrazolopyridine kinase inhibitors

#20

20120136000

2012-05-31

Tri-cyclic pyrazolopyridine kinase inhibitors

#21

20110318691

2011-12-29

RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME

#22

20110092698

2011-04-21

Heterocyclyl compounds

#23

20060241148

2006-10-26

Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls